HeathTech Startup Sugar.fit Gets $11 Million To Fight Diabetes
Last updated on November 2nd, 2023 at 10:21 am
Sugar.fit, a health-tech startup that focuses on diabetes care, has just secured $11 million in Series A funding. This is a major financial boost for the company, especially after its remarkable growth since they were founded in 2021.
So what is Sugar.fit all about? Well, the startup aims to manage and even reverse Type 2 and Pre-diabetes. It’s a one-stop solution for people struggling with these conditions.
The platform uses advanced devices like glucose monitors and fitness trackers to give real-time data. It also provides easy access to doctors and health coaches.
This way, people can understand how their lifestyle choices, like what they eat or how much they exercise, are affecting their sugar levels.
Now, you may be wondering what they plan to do with the $11 million. The funding will help Sugar.fit in expanding its services and products.
They are also planning to establish an offline presence, maybe through clinics or retail stores. Most importantly, they want to speed up research and development in the diabetes field.
This is crucial because diabetes is a major health concern in India. About 100 million people in the country are dealing with Type 2 diabetes, and another 130 million are at risk of pre-diabetes. Innovative solutions like Sugar.fit are much needed.
The startup’s approach is showing results too. Those who have been using the platform have seen a 2% drop in their HbA1c levels after just three months. HbA1c is a key measure of long-term blood sugar control, so that’s a big deal.
As of now, Sugar.fit has more than 25,000 users on its platform. And this number has grown eight times in the last 18 months, thanks to their paid subscriptions.
Also Read: Curefoods Takes A Slice Of Yumlane, What’s Cooking In Foodtech?
Sugar.fit got $11 million in Series A funding. They plan to use this money to offer more products, get into offline spaces, and also invest in research to better manage diabetes. The company aims to take a promising step in the fight against diabetes in India.
